<unk>  engineered heart<unk>  (TEHV) offer a new and advancing proposed treatment of creating a living heart<unk> for people who are in need of either a full or partial heart<unk> replacement. Currently, there are over a quarter of a million prosthetic heart<unk>  implanted annually, and the number of patients requiring replacement surgeries is only suspected to rise and even triple over the next fifty years. While current treatments offered such as mechanical<unk>  or biological<unk>  are not deleterious to one's health, they both have their own limitations in that mechanical<unk>  necessitate the lifelong use of anticoagulants while biological<unk>  are susceptible to structural degradation and reoperation. Thus, in situ (in its original position or place)<unk>  serves as a novel approach that explores the use creating a living heart<unk> composed of the host's own cells that is capable of growing, adapting, and interacting within the human body's biological system. Research has not yet reached the stage of clinical trials.
Tissue engineering of heart valves
Mitral valve repair
Heart valve repair
Aortic valve repair
Robot-assisted double heart valve replacement
Percutaneous aortic valve replacement
Valve-sparing aortic root replacement
Totally endoscopic coronary artery bypass surgery